These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1376509

  • 1. FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.
    Tze WJ, Tai J, Cheung SS, Ricordi C, Murase N, Starzl TE.
    Transplant Proc; 1992 Jun; 24(3):1034-6. PubMed ID: 1376509
    [No Abstract] [Full Text] [Related]

  • 2. Long-term survival of islet allografts in diabetic rats treated with FK 506.
    Tze WJ, Tai J, Cheung SS, Murase N, Ricordi C, Starzl TE.
    Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411
    [No Abstract] [Full Text] [Related]

  • 3. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
    Yasunami Y, Ryu S, Ueki M, Arima T, Ikeda S, Kamei T.
    Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
    [No Abstract] [Full Text] [Related]

  • 4. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
    Hisanaga M, Nakajima Y, Yabuuchi H, Nakano H.
    Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
    [No Abstract] [Full Text] [Related]

  • 5. Intraportal FK 506 improves intrahepatic islet allograft survival.
    Wang X, Berezniak R, Tafra L, Posselt A, Barker CF, Dafoe DC.
    Transplant Proc; 1991 Dec; 23(6):3211-2. PubMed ID: 1721412
    [No Abstract] [Full Text] [Related]

  • 6. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C, Cicalese L, Leach R, Braun M, Fung JJ, Starzl TE, Rao AS.
    Transplant Proc; 1999 Dec; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract] [Full Text] [Related]

  • 7. Leflunomide, a potential immunosuppressant for pancreatic islet transplantation.
    Guo Z, Chong AS, Shen J, Foster P, Sankary HN, McChesney L, Mital D, Jensik SC, Gebel H, Williams JW.
    Transplant Proc; 1997 Dec; 29(1-2):1296-7. PubMed ID: 9123314
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump.
    Ryu S, Yasunami Y.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):760. PubMed ID: 1703710
    [No Abstract] [Full Text] [Related]

  • 9. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients.
    Siebers U, Zekorn T, Horcher A, Klöck G, Houben R, Frank H, Bretzel RG, Zimmermann U, Federlin K.
    Transplant Proc; 1994 Apr; 26(2):787-8. PubMed ID: 8171662
    [No Abstract] [Full Text] [Related]

  • 10. Improvement in allograft survival of islets of Langerhans by pretreatment with deoxyguanosine.
    al-Abdullah IH, Kumar MS, al-Adnani MS, Abouna GM.
    Diabetes Res; 1991 Aug; 17(4):181-7. PubMed ID: 1823639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term survival of Wistar-Furth islet allografts in Lewis rats is associated with spontaneously tolerated orthotopic liver allografts.
    Wan X, Yu W, Yang H, al-Abdullah I, Coddington D, Bitter-Suermann H, Wright JR.
    Transplant Proc; 1994 Apr; 26(2):723-4. PubMed ID: 8171625
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of mice and rats as recipients for canine islet xenografts.
    Brayman KL, Morel P, Field J, Lloveras JJ, Leventhal J, Nakhleh R, Jessurun J, Platt J, Matas AJ, Najarian JS.
    Transplant Proc; 1992 Apr; 24(2):651-2. PubMed ID: 1566466
    [No Abstract] [Full Text] [Related]

  • 14. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H, Porter J, Monaco AP, Maki T.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract] [Full Text] [Related]

  • 15. Toward a new device for islet cell immunoisolation in pancreatic transplantation.
    van der Vliet JA, Bonthuis F, Marquet RL, Feyen J.
    Transplant Proc; 1992 Jun; 24(3):955. PubMed ID: 1604682
    [No Abstract] [Full Text] [Related]

  • 16. Donor-recipient cross has marked impact on islet survival and primary nonfunction.
    Weide LG.
    Transplant Proc; 1997 Jun; 29(4):2196. PubMed ID: 9193587
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y, Ryu S, Kamei T.
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract] [Full Text] [Related]

  • 18. Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs.
    Wahoff DC, Stephanian E, Gores PF, Soon-Shiong P, Hower C, Lloveras JK, Sutherland DE.
    Transplant Proc; 1994 Apr; 26(2):804. PubMed ID: 8171668
    [No Abstract] [Full Text] [Related]

  • 19. Islet transplantation in a subarachnoid cavity surrounding olfactory bulb of diabetic rats.
    Bloch K, Vanichkin A, Vardi P.
    Transplantation; 2013 Apr 27; 95(8):e54-7. PubMed ID: 23588202
    [No Abstract] [Full Text] [Related]

  • 20. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts.
    Marquet RL, Bouwman E, Bonthuis F, Wolvekamp MC, Kouwenhoven E, van Rooijen N, Scheringa M, Ijzermans JN.
    Transplant Proc; 1994 Apr 27; 26(2):766-7. PubMed ID: 8171654
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.